Skip to content
healthcare.dev
Get a free key

Hydralazine Hydrochloride

NDC 50228-183, Hydralazine Hydrochloride, tablet, from ScieGen Pharmaceuticals, Inc..

Product NDC
50228-183
Status
Listed
Labeler
ScieGen Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205236
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50228-183 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYDRALAZINE HYDROCHLORIDE25 mg/1

Pharmacologic classes

Arteriolar Vasodilation [PE]; Arteriolar Vasodilator [EPC]

Package NDCNDC-11Package
50228-183-0150228018301100 TABLET in 1 BOTTLE (50228-183-01)
50228-183-10502280183101000 TABLET in 1 BOTTLE (50228-183-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/500b7f76-5f4e-4e7d-85c3-18b9f66d7504

  • NADAC price for package 50228018301

    GET /v1/drugs/nadac/50228018301

  • NADAC price for package 50228018310

    GET /v1/drugs/nadac/50228018310

Use it

Look up 50228-183 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50228-183 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50228-183. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.